Genetic determinants of Neuroleptic Malignant Syndrome | C4C

  • Applicant: Olubanke Dzahini
  • Project ID: 14-117

Neuroleptic Malignant Syndrome (NMS) is a rare but potentially fatal side effect of antipsychotic treatment. The diagnosis of NMS remains a challenge as there are no universally accepted diagnostic criteria. Currently there are no known predictors which can help clinicians in identifying patients who are susceptible to developing NMS. There is some suggestion that genetics may increase the susceptibility in some individuals. Hence the aim of this study is to identify genetic markers that may predispose to development of NMS

The Clinical Record Interactive Search (CRIS) system is a computer system that allows researchers at the NIHR Maudsley Biomedical Research Centre (BRC) to carry out research using information from South London and Maudsley NHS Foundation Trust clinical records.

About

The Clinical Record Interactive Search has been developed in collboration with:

South London and Maudsley NHS Foundation Trust
NIHR Maudsley BRC